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Clustering of Device-Related Concerns and Type D
Personality Predicts Increased Distress in ICD Patients
Independent of Shocks1
SUSANNE S PEDERSEN, PH.D.,*† DOMINIC AMJ THEUNS, PH.D.,†
RUUD AM ERDMAN, PH.D.,†‡ and LUC JORDAENS, M.D., PH.D.†
From *CoRPS-Center of Research on Psychology in Somatic diseases, Tilburg University, Tilburg, The Netherlands;
†Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; and ‡Department
of Medical Psychology and Psychotherapy, Erasmus Medical Center, Rotterdam The Netherlands
Background: This study examined the impact of clustering of device-related concerns and Type D
personality on anxiety and depressive symptoms during a six-month period and the clinical relevance of
shocks, implantable cardioverter defibrillator (ICD) concerns, and Type D.
Methods: Consecutively implanted ICD patients (n = 176) completed questionnaires at baseline and six
months and were divided into four risk groups: (1) No risk factors (neither ICD concerns nor Type D); (2)
ICD concerns only; (3) Type D only; (4) Clustering (both ICD concerns and Type D).
Results: The prevalence of Type D and concerns were 21.6% and 34.7%. Analysis of variance for
repeated measures showed a reduction in anxiety over time (P < 0.001), with the risk groups exerting a
stable (P = 0.14) but differential effect (P < 0.001); the highest level was seen in the clustering group.
Similar results were found for depression, although depressive symptoms did not decrease (P = 0.08) and
the impact of clustering was less clear. These results were confirmed in adjusted analysis, with shocks (P
= 0.024) also being associated with anxiety but not depression. The impact of ICD concerns and Type D
personality on anxiety and depression at baseline and six months was large (≥0.8) compared to negligible
to moderate for shocks (0.0–0.6).
Conclusions: ICD patients with psychosocial risk factor clustering had the highest level of anxiety,
whereas the pattern for depression was less consistent. Shocks influenced outcomes, but the impact was
smaller compared to ICD concerns and Type D personality. It may be timely to expand the focus beyond
shocks when seeking to identify ICD patients at risk for adverse clinical outcome due to their psychological
profile. (PACE 2008; 31:20–27)
anxiety, clustering, depressive symptoms, ICD concerns, implantable cardioverter defibrillator, Type
D personality
Introduction
The superiority of the implantable car-
dioverter defibrillator (ICD) compared to antiar-
rhythmic medication to prevent sudden cardiac
death is well established both for primary and
secondary prevention.1–3 Hence, compared to pa-
tients with general cardiovascular disease psycho-
somatic research in ICD patients has primarily
focused on patient-centered outcomes, such as
anxiety and depression, with anxiety (24–87%)
being more prevalent than depression (24–33%)
in this patient group.4 The studying of these out-
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comes and their determinants is important in order
to be able to identify high-risk patients,5 as pre-
liminary evidence suggests that ICD patients may
benefit from psychological intervention and car-
diac rehabilitation in terms of reduced anxiety and
improved exercise capacity.6
Determinants of anxiety and depression in
ICD patients identified to date include an amalgam
of demographic, clinical (e.g., shocks), and psy-
chosocial factors, although it should be noted that
not all studies have been able to demonstrate a re-
lationship between shocks and these outcomes.7–9
Previous studies have shown that device-related
concerns, such as worrying about the ICD giving
a shock,10 and Type D personality9 are determi-
nants of anxiety and depression independently
of shocks. However, the latter studies were based
on a cross-sectional design and evaluated the in-
fluence of the two risk factors separately. Given
that psychosocial risk factors tend to cluster to-
gether within individuals (e.g., those who have
marital problems also tend to have higher levels
of depression compared to those with no marital
C©2008, The Authors. Journal compilation C©2008, Blackwell Publishing, Inc.
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problems),11 patients with both Type D personal-
ity and device-related concerns may be at greater
risk of adverse health outcomes, including anxiety
and depression, compared to patients with single
risk factors.
Type D personality refers to the tendency
to experience increased negative emotions paired
with nonexpression of these emotions.12 Type D is
an emerging risk factor in cardiovascular disease
that has been associated with multiple adverse
health outcomes, including mortality, morbidity,
impaired quality of life, and emotional distress, de-
spite appropriate medical treatment.13 The risk in-
curred by Type D personality on mortality and ma-
jor adverse clinical events range from 4- to 8-fold,
with the risk being independent of demographic
and clinical risk factors including disease sever-
ity.13 Type D reflects a normal personality disposi-
tion rather than psychopathology and is more than
negative affect, such as anxiety and depression, be-
cause the construct also stipulates how patients
deal with their high levels of negative emotions,
that is, showing a general preference for nonex-
pression due to fears of how others may react.12,13
To date, the cross-cultural validity of the construct
has been confirmed in Belgian, Danish, German,
and Italian samples.13
The objectives of this prospective study were
to (1) examine the impact of risk factor clustering
(i.e., device-related concerns and Type D personal-
ity) on anxiety and depressive symptoms during a
period of six months in ICD patients, and (2) eval-
uate the clinical relevance of shocks versus ICD
concerns and Type D personality as determinants
of anxiety and depressive symptoms.
Methods
Patients and Study Design
Consecutive patients receiving an ICD implan-
tation between August 2003 and July 2006 at the
Erasmus Medical Center, Rotterdam, The Nether-
lands, participating in the ongoing Mood and per-
sonality as precipitants of arrhythmia in patients
with an Implantable cardioverter Defibrillator: A
prospective Study (MIDAS) comprised the patient
sample for this study. MIDAS was designed to ex-
amine the impact of mood and personality on ar-
rhythmias. Recently, in a smaller sample of pa-
tients from the MIDAS study (n = 154) Type D
personality but not ICD indication was shown to
influence health-related quality of life adversely
three months postimplantation.14
Patients were excluded if they had a life ex-
pectancy less than one year, a history of psychiatric
illness other than affective/anxiety disorders, were
on the waiting list for heart transplantation, or had
insufficient knowledge of the Dutch language. Pa-
tients were asked to complete a set of psycholog-
ical questionnaires at baseline (i.e., one day prior
to ICD implantation) and at six months. These as-
sessment times coincided with clinical follow-up
visits to the hospital, with the ICD nurse asking
patients to fill out the questionnaires. Of 219 con-
secutive patients fulfilling the inclusion criteria,
211 (96.3% response rate) agreed to participate in
the study. However, analyses are based on 176 pa-
tients, since some patients died during follow-up
or did not complete questionnaires at six months.
A flow chart of the patient selection is presented
in Figure 1.
The MIDAS study protocol was approved by
the medical ethics committee of the hospital. The
study that was conducted to conform to the ethical
tenets developed by the World Medical Associa-
tion, as espoused in the Declaration of Helsinki.
Measures
Demographic and Clinical Variables
All demographic and clinical variables were
obtained at baseline. Demographic variables in-
cluded sex, age, marital status, and education.
Information on clinical variables, including indi-
cation for ICD implantation, cardiac resynchro-
nization therapy (CRT), coronary artery disease
(CAD) etiology, chronic heart failure (CHF), pre-
vious myocardial infarction (MI), previous per-
cutaneous coronary intervention (PCI), previous
coronary artery bypass graft surgery (CABG), dia-
betes, left ventricular ejection fraction (LVEF), ven-
tricular tachyarrhythmias and shocks during the
six-month follow-up period, and cardiac medi-
cation were obtained from the medical records.
Information on the use of psychotropic medication
Figure 1. Flow chart of patient selection.
PACE, Vol. 31 January 2008 21
PEDERSEN, ET AL.
was obtained through a purpose-designed ques-
tion.
Device-Related Concerns
Device-related concerns, as perceived by the
patient, were assessed with the ICD Concerns
(ICDC) questionnaire, which was originally devel-
oped in the UK,15 and later adapted and abbre-
viated for the Dutch setting.10 The ICDC consists
of eight-items (e.g. “I am worried about my ICD
firing” and “I am worried about symptoms/pain
associated with my ICD firing”) that are rated on
a 5-point Likert scale from 0 (not at all) to 4 (very
much so). A higher score indicates a higher level of
device-related concerns. The internal consistency
of the eight-item ICDC is good, with Cronbach’s α
= 0.91.10 The ICDC was administered at baseline.
Type D Personality
Type D personality was assessed with the 14-
item Type D Scale (DS14).12 The DS14 comprises
two normal and stable personality traits: negative
affectivity (e.g. “I often feel unhappy”; 7 items) and
social inhibition (e.g. “I am a closed kind of per-
son”; 7 items).11 Items are answered on a 5-point
Likert scale ranging from 0 (false) to 4 (true), with
a score range from 0–28 for both subscales. Type D
caseness is determined by means of a standardized
cut-off ≥10 on both subscales.12,16 The DS14 was
developed in cardiac patients and is a valid and re-
liable measure, with Cronbach’s alpha of 0.88/0.86
and three-month test-retest reliability r = 0.72/0.82
for the negative affectivity and social inhibition
subscales, respectively.12 A recent study showed
that Type D is a stable measure over an 18-month
period, and is not confounded by cardiac disease
severity and measures of anxiety and depression.17
In addition, it is the combination of traits rather
than the single trait that is associated with adverse
health outcomes, with Type D exerting an effect on
these outcomes independent of mood states, such
as anxiety and depression.18 The DS14 was admin-
istered at baseline
Anxiety and Depression
Symptoms of anxiety and depression were
evaluated with the Hospital Anxiety and Depres-
sion Scale (HADS).19,20 Items are answered on a 4-
point Likert scale from 0–3 (score range 0–21), with
seven items contributing to each subscale. Proba-
ble clinical levels of anxiety and depression are in-
dicated by a cut-off score ≥8 for both subscales.21
The HADS is a valid and reliable instrument that
has been used across the world in cardiac and non-
cardiac populations.21 The HADS was adminis-
tered both at baseline and at six months follow-
up.
Statistical Analyses
Prior to statistical analyses, ICD concerns were
dichotomized using the highest tertile to indi-
cate high levels of device-related concerns. Sub-
sequently, four risk groups were formed on the ba-
sis of the psychological factors ICD concerns and
Type D personality in order to examine the impact
of clustering versus single risk factors, as follows:
(1) No risk factors (neither ICD concerns nor Type
D); (2) ICD concerns only; (3) Type D only; (4) Clus-
tering (both ICD concerns and Type D). Nominal
variables were compared with the Chi-square test
(Fisher’s exact test when appropriate) and contin-
uous variables with analysis of variance (ANOVA)
with a post hoc Bonferroni correction. ANOVA for
repeated measures was used to evaluate changes
in anxiety and depression over time, stratified by
the risk groups. Analysis of covariance (ANCOVA)
was used to rule out the potential confounding ef-
fect of demographic and clinical risk factors on
anxiety and depression. A priori, sex, age, marital
status (defined as single vs married/partner), edu-
cation (defined as lower (i.e., ≤12 years) vs higher
education (i.e., ≥13 years), ICD indication, CRT,
CAD etiology, CHF, diabetes, and shocks, were se-
lected as covariates for the ANCOVA. Cohen’s ef-
fect size index22 was used to evaluate the clini-
cal relevance of shocks, ICD concerns, and Type D
personality as determinants of anxiety and depres-
sion. Means and standard deviations for between-
group differences on anxiety and depression, used
as a basis for calculating Cohen’s d, were derived
from multivariate analysis of variance (MANOVA).
According to Cohen, an effect size of 0.2 is consid-
ered as small, 0.5 as moderate, and 0.8 as large.22
All tests were two-tailed. A P-value <0.05 was
used to indicate statistical significance. All analy-
ses were performed using SPSS 14.0 for Windows
(Chicago, IL, USA).
Results
Patients who participated in the study (n =
211) did not differ systematically on demographic
and clinical characteristics, including on ventric-
ular tachyarrhythmias and shocks, compared to
nonparticipants (n = 8), except for participants be-
ing more likely to use β-blockers (80.8% vs 37.5%;
P = 0.011) and to have a lower LVEF (mean = 27.7
± 10.3 vs mean = 40.0 ± 13.1; P = 0.022) than
nonparticipants. The latter analysis was based on
134 patients (participants: n = 130; nonpartici-
pants: n = 4), given that echocardiography was not
performed in all patients. No information on the
use of psychopharmaca was available for nonpar-
ticipants, given that this was a purpose-designed
question in the questionnaire.
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Baseline Patient Characteristics Stratified by
Risk Groups
No statistically significant differences were
found on demographic and clinical baseline char-
acteristics, including medication, between the four
risk groups (Table I).
Of the 176 patients, 35 (19.9%) experienced a
ventricular tachyarrhythmia during the six-month
follow-up period, with 23 (13%) receiving a shock.
There were no statistically significant differences
between the four risk groups on ventricular ar-
rhythmias (none: 17.8%; Type D only: 28.6%; con-
cerns only: 24.3%; both: 16.7%; P = 0.63), nor on
shocks (none: 13.9%; Type D only: 21.4%; con-
cerns only: 8.1%; both: 12.5%; P = 0.61) during
the follow-up period.
Type D Personality and ICD Concerns
The prevalence of Type D personality was
21.6%, whereas 34.7% scored high on ICD con-
Table I.
Baseline Patient Characteristics Stratified by Risk Groups*
None Type D ICD Concerns Clustering
(n = 101) (n = 14) (n = 37) (n = 24) P
Demographics
Males 82.2 85.7 75.7 79.2 0.82
Age, mean (SD) 58.4 (13.2) 62.4 (9.6) 58.9 (9.8) 59.6 (10.5) 0.70
Single 6.9 0 5.4 12.5 0.62
Lower education1 62.4 71.4 63.9 56.5 0.84
Clinical variables
Indication (secondary) 44.6 42.9 48.6 41.7 0.95
Resynchronization therapy 34.7 21.4 27.0 37.5 0.65
CAD etiology 58.4 50.0 59.5 66.7 0.79
Chronic heart failure 50.5 35.7 32.4 45.8 0.26
Previous MI 49.5 42.9 56.8 45.8 0.79
Previous PCI 14.0 15.4 19.4 39.1 0.06
Previous CABG 20.8 14.3 27.0 21.7 0.79
Diabetes 9.0 7.7 5.6 8.7 0.94
LVEF, mean (SD)2 29.2 (11.2) 25.6 (6.4) 26.5 (11.8) 25.7 (9.8) 0.51
Medication
Amiodarone 21.4 28.6 40.5 25.0 0.16
Beta-blockers 83.7 78.6 75.7 75.0 0.56
Diuretics 63.9 64.3 51.4 62.5 0.62
ACE-inhibitors 74.2 64.3 70.3 79.2 0.73
Statins 53.1 64.3 50.0 75.0 0.19
Digoxin 20.6 7.1 8.3 20.8 0.29
Psychopharmaca 16.8 14.3 22.2 29.2 0.51
* Presented as % unless otherwise indicated.
1 Lower education ≤12 years.
2 Echocardiography was only performed in a subsample of patients.
CABG = coronary artery bypass graft surgery; CAD = coronary artery disease; LVEF = left ventricular ejection fraction; MI =
myocardial infarction; PCI = percutaneous coronary intervention.
cerns. Given that the primary objective of this
study was to investigate the impact of the clus-
tering of Type D personality and baseline ICD con-
cerns, their interrelationship was first examined.
As shown in Figure 2, Type D patients were more
likely to report device-related concerns compared
to non-Type D patients (63.2% vs 26.8%; P <
0.001).
Prevalence of Anxiety and Depression Stratified
by Risk Groups
The prevalence of anxiety was higher in the
clustering group compared to the other groups
both at baseline and at six months. At baseline,
the prevalence of anxiety was 83.3% in the cluster-
ing group followed by 40.5% in the ICD concerns
group, with prevalences of 14.3% in the Type D
and the 15.8% in the no risk groups being almost
similar (P < 0.001). At six months, the prevalence
in the clustering group was 50% versus 28.6% in
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Figure 2. Prevalence of baseline ICD concerns stratified
by Type D personality.* * Mean (SD) scores are pre-
sented below.
the Type D only, 27.0% in the ICD concerns only,
and 14.9% in the no risk groups (P < 0.003).
Similarly, for depression at baseline the preva-
lence in the clustering group was 66.7% versus
50.0% in the Type D only, 27.0% in the concerns
only, and 18.8% in the no risk groups (P < 0.001).
At six months, the prevalence was 41.7% in the
clustering group compared to 42.9% in the Type D
only group, 24.3% in the ICD concerns only group,
and 14.9% in the no risk group (P = 0.008).
Changes in Anxiety and Depression Stratified by
Risk Groups (Unadjusted Analysis)
ANOVA for repeated measures showed that
the within-subjects effect for time in relation to
anxiety was significant (F (1,172) = 17.719; P <
0.001), indicating that patients experienced a gen-
eral reduction in anxiety between baseline and six
months follow-up (Fig. 3, top). The risk groups ex-
erted a stable effect on anxiety over time, as in-
dicated by the nonsignificant interaction effect for
time by risk groups (F (3,172) = 1.858; P = 0.14),
but the groups experienced different levels of anx-
iety (F (3,172) = 26.019; P < 0.001). The highest
level of anxiety was seen in the clustering group,
with all post hoc comparisons being significant (ps
< 0.05), except between the no risk group and Type
D only and Type D and ICD concerns only.
Similar results were found for depression, al-
though the decrease in depressive symptoms over
time was not statistically significant (F (1,172) =
7.198; P = 0.08) (Fig. 3, bottom). Again the inter-
action effect for time by risk groups was not sig-
nificant (F (3,172) = 1.429; P = 0.24), indicating
that the risk groups also exerted a stable effect on
depression over the six-month period (F (3,172) =
15.645; P < 0.001). Nevertheless, the risk groups
reported significantly different levels of depres-
sion, although the only significant post hoc com-
parisons were found between the no risk and Type
Figure 3. Mean anxiety and depression scores at base-
line and six months stratified by risk groups.* * ANOVA
for repeated measures (univariable analysis); a high
score indicates more symptoms.
D only groups, no risk and the clustering groups,
and ICD concerns only and the clustering groups
(ps < 0.05).
Changes in Anxiety and Depression Stratified by
Risk Groups (Adjusted Analysis)
In order to rule out that the influence of the
risk groups on anxiety and depression could be at-
tributed to potential confounding by shocks and
other baseline characteristics, ANCOVAs for re-
peated measures were performed, adjusting for
sex, age, marital status, education, ICD indication,
CRT, CAD etiology, CHF, diabetes, and shocks.
For anxiety, the only within-subjects interac-
tion effect for time by covariates that was signifi-
cant was that for time by shock (F (1,156) = 3.965;
P = 0.048). A view of the plot of the estimated
marginal means showed that time had a differen-
tial influence on anxiety for shocked versus non-
shocked patients, with those experiencing a shock
reporting increased levels of anxiety at six months
follow-up compared to nonshocked who reported
a decrease in symptoms of anxiety. The between
subjects effect for the four risk groups (F (3,156)
= 25.602; P < 0.001), age (F (1,156) = 4.075; P=
0.045), lower education (F (1,156) = 7.119; P =
0.008), and shocks (F (1,156) = 5.160; P = 0.024)
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were also statistically significant in adjusted anal-
ysis, whereas there was a trend for CAD etiology
(F (1,156) = 3.566; P = 0.061). Taken together, the
influence of the four risk groups on anxiety re-
mained significant despite adjustment for demo-
graphic and clinical baseline characteristics in-
cluding shocks.
For depression, there were no significant
within-subjects interaction effects for time by co-
variates. The between subjects effect for the four
risk groups (F (3,156) = 15.158; P < 0.001) and
lower education (F (1,156) = 5.725; P = 0.018) were
significant, whereas shocks (F (1,156) = 2.583; P =
0.11) were not related to depression in adjusted
analysis. Similar to the results for anxiety, there
was a trend for CAD etiology (F (1,156) = 3.208;
P= 0.075). These results show that the four risk
groups had a significant impact despite adjustment
for demographic and clinical baseline characteris-
tics including shocks.
The overall results did not change when
adding LVEF as a covariate to the ANCOVAs, in-
dicating that the impact of clustering on anxiety
and depressive symptoms could not be attributed
to cardiac disease severity.
Clinical Relevance of Shocks, ICD Concerns,
and Type D Personality as Determinants of
Anxiety and Depression
Effect sizes for the impact of shocks, ICD con-
cerns, and Type D personality on anxiety and de-
pression at baseline and six months are shown in
Figure 4. The influence of shocks on anxiety was
negligible at baseline but moderate to large at six
months. The negligible effect of shocks at baseline
reflects that shocks occurred during the follow-up
period (i.e., after the baseline assessment). By con-
trast, the impact of ICD concerns and Type D were
large at both time points. For depression, the effect
size for shocks was negligible at baseline but small
to moderate at follow-up, whereas the effect sizes
for ICD concerns and Type D personality were large
at both time points.
Discussion
In this study, symptoms of anxiety but not
depression abated over time. However, a dif-
ferential pattern in the course of anxiety was
seen in shocked versus nonshocked patients, with
shocked patients experiencing increased levels of
anxiety at six months follow-up compared to non-
shocked who reported a decrease in anxiety. The
clustering of device-related concerns and Type D
personality was associated with the highest levels
of anxiety at both baseline and six months com-
pared to patients with no or one risk factor. The
impact of clustering was less clear for depression,
with higher depression scores in the clustering
Figure 4. Clinical relevance of shocks, ICD concerns
and Type D personality as determinants of anxiety
and depression at baseline and six months post-ICD
implantation.* * ES = Effect size.
group at baseline, whereas at follow-up depression
levels were similar in patients with risk factor clus-
tering and the single risk factor Type D personal-
ity. Shocks had a larger influence on anxiety than
on depression, but generally the psychological risk
factors ICD concerns and Type D personality had
a greater influence on both anxiety and depression
relative to shocks, as indicated by Cohen’s effect
size index.
A paucity of studies have investigated the im-
pact of clustering of psychosocial risk factors in pa-
tients with cardiovascular disease, although these
risk factors tend to cluster together within indi-
viduals and may incur a higher risk than single
risk factors.11 In this study, patients with cluster-
ing of device-related concerns and Type D person-
ality, two factors that have previously been associ-
ated with increased anxiety and depression in ICD
patients,9,10 experienced higher levels of anxiety
compared to patients with no or one risk factor.
The impact of clustering was less clear for depres-
sion, however. This finding supports the notion
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that it may be timely to shift focus from a “single-
risk factor approach” to study the impact of psy-
chosocial risk factor clustering in order to obtain
the most accurate risk estimation for individual pa-
tients.11 This is particularly important, given that
mood states, such as anxiety and depression, have
been shown to influence clinical outcome,23 ad-
herence,24 and healthy lifestyle changes25 in pa-
tients with cardiovascular disease. Hence, if the
more deleterious influence of psychosocial risk
factor clustering in ICD patients compared to sin-
gle risk factors is confirmed in future studies, these
high-risk patients should be identified in clini-
cal practice and offered adjunctive psychological
intervention. Preliminary evidence indicates that
such patients may benefit from psychological in-
tervention (e.g., cognitive behavioral therapy) in
combination with cardiac rehabilitation in par-
ticular in terms of reducing anxiety.6 Of note, in
this study risk factor clustering had the most pro-
found and consistent effect on anxiety. Identifica-
tion of these high-risk patients would likely also
lead to a more optimal and cost-effective allocation
of healthcare resources, as patients with a low-risk
psychological profile are unlikely to derive any no-
table benefit from psychological intervention sim-
ply because they do not need it.
The influence of shocks on patient-centered
outcomes, such as mood states and quality of life,
in ICD patients is the subject of some debate, with
some26–29 but not all studies7–10,14,30,31 confirming
a relationship between shocks and these outcomes.
The inconsistency in findings can in part be at-
tributed to differences in study designs, including
whether factors that may potentially compete with
shocks as a determinant of outcome were stud-
ied, and the way that shocks was assessed (e.g.,
self-report vs objectively measured) and quantified
(e.g., shocks/no shocks vs number of shocks). The
results of the Canadian Implantable Defibrillator
Study highlight how the quantification of shocks
may influence the results, as only patients who had
experienced ≥5 shocks were at risk for impaired
quality of life.31 Although shocks were associated
with anxiety in adjusted analysis but not with de-
pression in this study, the importance of the risk
factors device-related concerns and Type D per-
sonality was relatively larger than shocks, as indi-
cated by Cohen’s effect size index. This finding is
consistent with that of Sears and colleagues, who
found that shocks contributed significantly to the
explained variance in quality of life, but the con-
tribution was relatively small compared to that of
other factors, such as history of depression, trait
anxiety, trait optimism, and social support.27 With
changes in the programming of the ICD and the use
of new antitachycardia pacing therapies,32 which
leads to a reduction in shocks and better quality of
life as shown in the PainFree RX II trial,33 it may
be timely to expand the focus beyond shocks when
studying determinants of adverse health outcomes
in ICD patients.
This study has some limitations. First, the
baseline assessment (i.e., one day prior to implan-
tation) is not optimal, as emotional distress at this
time may reflect procedure-related distress. How-
ever, this time point was adapted to ensure stan-
dardization of assessment, as all patients were hos-
pitalized one day prior to implantation. Second,
the analyses were only adjusted for LVEF in a sub-
sample of patients, given that echocardiography
was not performed in all patients. Nevertheless,
the overall results did not change when adding
LVEF as a covariate to the analyses. Third, the
follow-up period only extended to six months,
with studies needing to confirm the findings of
this study long term. Fourth, we had no informa-
tion on lifestyle factors, such as smoking, extent
of physical exercise, and adherence to dietary ad-
vice if given, which may have influenced outcome.
Despite these limitations, this study also has sev-
eral strengths, including the high response rate,
the prospective study design, focus on risk factor
clustering, use of a disease-specific measure (i.e.,
the ICDC questionnaire), and the inclusion of per-
sonality factors, which is a novel approach in ar-
rhythmia research.9
In conclusion, ICD patients with risk factor
clustering had higher anxiety scores compared to
patients with single or no risk factors, although the
pattern was less consistent for depression. Shocks
were shown to influence outcomes, but the impact
was generally smaller compared to that of ICD con-
cerns and Type D personality. Patients with risk
factor clustering should not be overlooked in clin-
ical practice, as they may also be at higher risk
of other adverse health outcomes, including poor
prognosis. The Type D Scale (DS14) could be used
as a screening tool in clinical practice in order to
identify high-risk patients, as advocated by oth-
ers.13,34 The scale is brief, comprises little burden
to patients, is unconfounded by somatic symp-
toms12 and disease severity,17 and reflects a normal
personality construct rather than psychopathol-
ogy. Finally, it may be timely to expand the focus
beyond shocks when seeking to identify patients
at risk for psychological maladjustment following
ICD implantation.
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